{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:54:40Z","timestamp":1767837280926,"version":"3.49.0"},"reference-count":55,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Children born preterm are at increased risk of adverse neurodevelopmental outcomes and may be particularly vulnerable to the effects of gastric acid suppression during infancy.<\/jats:p><\/jats:sec>Objective<\/jats:title>To assess whether early acid suppressant use in infants born extremely preterm is associated with poorer neurodevelopmental outcomes.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>The Extremely Low Gestational Age Newborn study was a multicenter, longitudinal cohort study of infants born before 28 weeks\u2019 gestational age between March 22, 2002, and August 31, 2004. The current analyses were performed from September 12, 2020, through September 22, 2022. Of the 1506 infants enrolled, 284 died before discharge and 22 died before 24 months of age. An additional 2 died before age 10 years, leaving 1198 (79.5%) eligible for a visit. Of these, 889 (74%) participated in the visit at age 10. At age 10 years, the association of early-life acid suppressant use with neurocognitive, neurodevelopmental, and psychiatric symptomatology was assessed.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Acid suppressant use before 24 months of age was determined from medical records and from questionnaires administered to mothers.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Neurodevelopmental assessments at age 10 years included the School-Age Differential Ability Scales\u2013II, the Developmental Neuropsychological Assessment-II, the Autism Diagnostic Observation Schedule-2, the Social Responsiveness Scale-2, and the Child Symptom Inventory-4 for attention-deficit\/hyperactivity disorder (ADHD), depression, and anxiety.<\/jats:p><\/jats:sec>Results<\/jats:title>Of the 889 participants assessed at age 10 years (mean [SD] age, 9.97 [0.67] years; mean [SD] gestational age at birth, 26.1 [1.3] weeks; 455 [51.2%] male), 368 (41.4%) had received acid suppressants by 24 months of age. Associations were observed between acid suppressant use and decreased full-scale IQ z<\/jats:italic> score (adjusted \u03b2, \u22120.29; 95% CI, \u22120.45 to \u22120.12), verbal IQ z<\/jats:italic> score (adjusted \u03b2, \u22120.34; 95% CI, \u22120.52 to \u22120.15), nonverbal IQ z<\/jats:italic> score (adjusted \u03b2, \u22120.22; 95% CI to \u22120.39 to \u22120.05), working memory z<\/jats:italic> score (adjusted \u03b2, \u22120.26; 95% CI to \u22120.45, \u22120.08), autism spectrum disorder (adjusted relative risk, 1.84; 95% CI, 1.15-2.95), and epilepsy (adjusted relative risk, 2.07; 95% CI, 1.31 to 3.35). Results were robust to multiple sensitivity analyses. Use of acid suppressants was not associated with inhibitory control, ADHD, anxiety, or depression.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>The results of this cohort study suggest that early-life use of acid suppressants in extremely preterm infants may be associated with poorer neurodevelopmental outcomes and add to evidence indicating caution in use of these agents.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.41943","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T16:33:48Z","timestamp":1668530028000},"page":"e2241943","source":"Crossref","is-referenced-by-count":6,"title":["Analysis of Neurodevelopment in Children Born Extremely Preterm Treated With Acid Suppressants Before Age 2 Years"],"prefix":"10.1001","volume":"5","author":[{"given":"Elizabeth T.","family":"Jensen","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wesley","family":"Jackson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachana","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Joseph","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Neurobiology, Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl C. K.","family":"Kuban","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston Medical Center, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Msall","sequence":"additional","affiliation":[{"name":"Kennedy Research Center on Intellectual and Neurodevelopmental Disabilities, University of Chicago Pritzker School of Medicine, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Washburn","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Fry","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"South","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina"},{"name":"Department of Pediatrics, Wake Forest University School of Medicine, Winston-Salem, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Michael","family":"O\u2019Shea","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"issue":"3","key":"zoi221182r1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/MPG.0000000000001889","article-title":"Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.","volume":"66","author":"Rosen","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"zoi221182r2","doi-asserted-by":"publisher","first-page":"e1684","DOI":"10.1542\/peds.2013-0421","article-title":"Gastroesophageal reflux: management guidance for the pediatrician.","volume":"131","author":"Lightdale","year":"2013","journal-title":"Pediatrics"},{"issue":"1","key":"zoi221182r3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1542\/peds.2018-1061","article-title":"Diagnosis and management of gastroesophageal reflux in preterm infants.","volume":"142","author":"Eichenwald","year":"2018","journal-title":"Pediatrics"},{"issue":"2","key":"zoi221182r4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.12788\/jhm.3291","article-title":"Impact of the Choosing Wisely campaign recommendations for hospitalized children on clinical practice: trends from 2008 to 2017.","volume":"15","author":"Reyes","year":"2020","journal-title":"J Hosp Med"},{"issue":"12","key":"zoi221182r5","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1007\/s00431-020-03837-8","article-title":"Use of anti-reflux medications in infants under 1 year of age: a retrospective drug utilization study using national prescription reimbursement data.","volume":"179","author":"O\u2019Reilly","year":"2020","journal-title":"Eur J Pediatr"},{"key":"zoi221182r6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jpeds.2016.03.059","article-title":"Neonatal histamine-2 receptor antagonist and proton pump inhibitor treatment at United States children\u2019s hospitals.","volume":"174","author":"Slaughter","year":"2016","journal-title":"J Pediatr"},{"key":"zoi221182r7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011785.pub2","article-title":"Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants.","volume":"7","author":"Green","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"19","key":"zoi221182r8","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1001\/jama.2018.5690","article-title":"Trends in prescription medication use among children and adolescents\u2014United States, 1999-2014.","volume":"319","author":"Hales","year":"2018","journal-title":"JAMA"},{"issue":"6","key":"zoi221182r9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1542\/peds.2016-1977","article-title":"Use of gastroesophageal reflux medications in premature infants after NICU discharge.","volume":"138","author":"D\u2019Agostino","year":"2016","journal-title":"Pediatrics"},{"issue":"4","key":"zoi221182r10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5863\/1551-6776-19.4.283","article-title":"Proton pump inhibitor prescribing patterns in newborns and infants.","volume":"19","author":"Illueca","year":"2014","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"6","key":"zoi221182r11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s40272-018-0311-3","article-title":"Optimizing the use of medications and other therapies in infant gastroesophageal reflux.","volume":"20","author":"Ciciora","year":"2018","journal-title":"Paediatr Drugs"},{"issue":"4","key":"zoi221182r12","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jpeds.2008.09.054","article-title":"Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.","volume":"154","author":"Orenstein","year":"2009","journal-title":"J Pediatr"},{"issue":"5","key":"zoi221182r13","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.jpeds.2015.02.061","article-title":"Limited efficacy of antigastroesophageal reflux medications in children.","volume":"166","author":"Berman","year":"2015","journal-title":"J Pediatr"},{"issue":"12","key":"zoi221182r14","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1001\/jamaoto.2018.1919","article-title":"Association of proton pump inhibitors with hospitalization risk in children with oropharyngeal dysphagia.","volume":"144","author":"Duncan","year":"2018","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"1","key":"zoi221182r15","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2625","article-title":"Early acid suppression therapy exposure and fracture in young children.","volume":"144","author":"Malchodi","year":"2019","journal-title":"Pediatrics"},{"issue":"3","key":"zoi221182r16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1345\/aph.1M519","article-title":"Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.","volume":"44","author":"Higginbotham","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"1","key":"zoi221182r17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/gutjnl-2017-314971","article-title":"Antibiotic and acid-suppression medications during early childhood are associated with obesity.","volume":"68","author":"Stark","year":"2019","journal-title":"Gut"},{"issue":"6","key":"zoi221182r18","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2018.0315","article-title":"Association between use of acid-suppressive medications and antibiotics during infancy and allergic diseases in early childhood.","volume":"172","author":"Mitre","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"6","key":"zoi221182r19","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-0857","article-title":"CYP2C19 phenotype and risk of proton pump inhibitor-associated infections.","volume":"144","author":"Bernal","year":"2019","journal-title":"Pediatrics"},{"key":"zoi221182r20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.712939","article-title":"Acid-suppressive drugs and risk of fracture in children and young adults: a meta-analysis of observational studies.","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"issue":"4","key":"zoi221182r21","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1001\/jamapediatrics.2020.5710","article-title":"Association between proton pump inhibitor use and risk of asthma in children.","volume":"175","author":"Wang","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"1","key":"zoi221182r22","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1542\/peds.2011-0796","article-title":"Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns.","volume":"129","author":"Terrin","year":"2012","journal-title":"Pediatrics"},{"key":"zoi221182r23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neuroscience.2018.11.048","article-title":"The acute influence of acid suppression with esomeprazole on gastrointestinal microbiota and brain gene expression profiles in a murine model of restraint stress.","volume":"398","author":"MacLaren","year":"2019","journal-title":"Neuroscience"},{"issue":"4","key":"zoi221182r24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/19490976.2017.1284732","article-title":"The influence of proton pump inhibitors and other commonly used medication on the gut microbiota.","volume":"8","author":"Imhann","year":"2017","journal-title":"Gut Microbes"},{"issue":"7","key":"zoi221182r25","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.v32.7","article-title":"Proton pump inhibitors enhance intestinal permeability via dysbiosis of gut microbiota under stressed conditions in mice.","volume":"32","author":"Takashima","year":"2020","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"zoi221182r26","doi-asserted-by":"publisher","first-page":"17280","DOI":"10.1038\/s41598-019-53622-3","article-title":"Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory.","volume":"9","author":"Makunts","year":"2019","journal-title":"Sci Rep"},{"key":"zoi221182r27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.earlhumdev.2019.03.003","article-title":"Associations between preterm infant stress, epigenetic alteration, telomere length and neurodevelopmental outcomes: a systematic review.","volume":"131","author":"Casavant","year":"2019","journal-title":"Early Hum Dev"},{"issue":"11","key":"zoi221182r28","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.earlhumdev.2009.08.060","article-title":"The ELGAN study of the brain and related disorders in extremely low gestational age newborns.","volume":"85","author":"O\u2019Shea","year":"2009","journal-title":"Early Hum Dev"},{"issue":"12","key":"zoi221182r29","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00247-007-0605-z","article-title":"Observer variability assessing US scans of the preterm brain: the ELGAN study.","volume":"37","author":"Kuban","year":"2007","journal-title":"Pediatr Radiol"},{"issue":"4","key":"zoi221182r30","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jpeds.2008.04.013","article-title":"An algorithm for identifying and classifying cerebral palsy in young children.","volume":"153","author":"Kuban","year":"2008","journal-title":"J Pediatr"},{"issue":"10","key":"zoi221182r31","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1177\/08830738050200101001","article-title":"Video and CD-ROM as a training tool for performing neurologic examinations of 1-year-old children in a multicenter epidemiologic study.","volume":"20","author":"Kuban","year":"2005","journal-title":"J Child Neurol"},{"issue":"4","key":"zoi221182r32","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/pr.2017.82","article-title":"Cognitive functioning at the age of 10?years among children born extremely preterm: a latent profile approach.","volume":"82","author":"Heeren","year":"2017","journal-title":"Pediatr Res"},{"key":"zoi221182r33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.pediatrneurol.2015.09.016","article-title":"A novel parent questionnaire for the detection of seizures in children.","volume":"54","author":"Douglass","year":"2016","journal-title":"Pediatr Neurol"},{"issue":"4","key":"zoi221182r34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/BF02179373","article-title":"The pre-linguistic autism diagnostic observation schedule.","volume":"25","author":"DiLavore","year":"1995","journal-title":"J Autism Dev Disord"},{"issue":"9","key":"zoi221182r35","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1097\/01.chi.0000227880.42780.0e","article-title":"Combining information from multiple sources in the diagnosis of autism spectrum disorders.","volume":"45","author":"Risi","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"zoi221182r37","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/00004583-200205000-00018","article-title":"A DSM-IV-referenced screening instrument for preschool children: the Early Childhood Inventory-4.","volume":"41","author":"Sprafkin","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"zoi221182r38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/DBP.0000000000000436","article-title":"Neurocognitive correlates of attention-deficit hyperactivity disorder symptoms in children born at extremely low gestational age.","volume":"38","author":"Scott","year":"2017","journal-title":"J Dev Behav Pediatr"},{"issue":"8","key":"zoi221182r39","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/apa.2017.106.issue-8","article-title":"Observer variability identifying attention deficit\/hyperactivity disorder in 10-year-old children born extremely preterm.","volume":"106","author":"Leviton","year":"2017","journal-title":"Acta Paediatr"},{"key":"zoi221182r40","doi-asserted-by":"publisher","year":"2010","DOI":"10.1186\/1753-2000-4-1"},{"issue":"1","key":"zoi221182r41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00001648-199901000-00008","article-title":"Causal diagrams for epidemiologic research.","volume":"10","author":"Greenland","year":"1999","journal-title":"Epidemiology"},{"issue":"6","key":"zoi221182r42","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/jcpp.2002.43.issue-6","article-title":"Cognitive profiles and social-communicative functioning in children with autism spectrum disorder.","volume":"43","author":"Joseph","year":"2002","journal-title":"J Child Psychol Psychiatry"},{"key":"zoi221182r43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1076\/chin.5.1.1.7075","article-title":"Subtypes of pervasive developmental disorder: clinical characteristics.","volume":"5","author":"Fein","year":"1999","journal-title":"Child Neuropsychol"},{"issue":"1","key":"zoi221182r44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40168-016-0225-7","article-title":"Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study.","volume":"5","author":"Kang","year":"2017","journal-title":"Microbiome"},{"key":"zoi221182r45","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fcimb.2017.00444","article-title":"The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A prospective longitudinal interventional study.","volume":"7","author":"Castellani","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"zoi221182r46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1128\/mSystems.00848-20","article-title":"The gut microbiome in autism: study-site effects and longitudinal analysis of behavior change.","volume":"6","author":"Fouquier","year":"2021","journal-title":"mSystems"},{"issue":"7","key":"zoi221182r47","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1007\/s10620-008-0528-z","article-title":"Transmucosal gastric leak induced by proton pump inhibitors.","volume":"54","author":"Murray","year":"2009","journal-title":"Dig Dis Sci"},{"issue":"5","key":"zoi221182r48","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1053\/j.gastro.2020.12.016","article-title":"Proton pump inhibitors reduce duodenal eosinophilia, mast cells, and permeability in patients with functional dyspepsia.","volume":"160","author":"Wauters","year":"2021","journal-title":"Gastroenterology"},{"key":"zoi221182r49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13229-016-0110-z","article-title":"Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders.","volume":"7","author":"Fiorentino","year":"2016","journal-title":"Mol Autism"},{"issue":"4","key":"zoi221182r50","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/MPG.0b013e3181dcc4a5","article-title":"Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives.","volume":"51","author":"de Magistris","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"zoi221182r51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577607","article-title":"Intestinal permeability correlates with behavioural severity in very young children with ASD: a preliminary study.","volume":"357","author":"Teskey","year":"2021","journal-title":"J Neuroimmunol"},{"key":"zoi221182r52","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4853695","article-title":"Possible effects of proton pump inhibitors on hearing loss development.","volume":"2019","author":"Wicinski","year":"2019","journal-title":"Biomed Res Int"},{"issue":"6","key":"zoi221182r53","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/bcpt.2019.124.issue-6","article-title":"Use of proton pump inhibitors among Danish children: a 16-year register-based nationwide study.","volume":"124","author":"Aznar-Lou","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"zoi221182r54","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100129","article-title":"Paediatric outpatient prescriptions in France between 2010 and 2019: a nationwide population-based study: paediatric outpatient prescriptions in France, 2010 to 2019.","volume":"7","author":"Taine","year":"2021","journal-title":"Lancet Reg Health Eur"},{"issue":"8","key":"zoi221182r55","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1177\/0009922815604596","article-title":"Trends in oral antibiotic, proton pump inhibitor, and histamine 2 receptor blocker prescription patterns for children compared with adults: implications for Clostridium difficile infection in the community.","volume":"55","author":"Faden","year":"2016","journal-title":"Clin Pediatr (Phila)"},{"key":"zoi221182r36","author":"Constantino","year":"2012"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2798448\/jensen_2022_oi_221182_1667580075.17382.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T16:33:51Z","timestamp":1668530031000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2798448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.41943","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]}}}